Chlortetracycline hydrochloride
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-04622 |
| CAS | 64-72-2 |
| Molecular Weight | 515.34 |
| Molecular Formula | C22H23ClN2O8.HCl |
| Purity | >98% |
Online Inquiry
Description
Chlortetracycline hydrochloride is the first identified tetracycline antibiotic. It is produced by the strain of Streptomyces. It can be used for the treatment of bacterial diseases such as chicken mycoplasma synovialis, ornithobacter rhinotrachealis, Escherichia coli, and Clostridium weischii.
Specification
| Related CAS | 57-62-5 (free base) |
| Synonyms | 7-Chlortetracycline hydrochloride; NSC 13252; (4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Hydrochloride; Aureociclina; Aureocycline; Aureomycin Hydrochloride; Aureomycin Monohydrochloride; Biomycin Hydrochloride; Chlortetracyclinium Chloride; Isphamycin |
| Storage | Store at -20°C |
| IUPAC Name | (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride |
| Canonical SMILES | CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl |
| InChI | InChI=1S/C22H23ClN2O8.ClH/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21;/h4-5,7-8,15,26-27,30,32-33H,6H2,1-3H3,(H2,24,31);1H/t7-,8-,15-,21-,22-;/m0./s1 |
| InChI Key | QYAPHLRPFNSDNH-MRFRVZCGSA-N |
| Source | Streptomyces sp. |
Properties
| Appearance | Light Yellow to Yellow Solid |
| Boiling Point | 694.1°C at 760 mmHg |
| Melting Point | 210-215°C (dec.) |
| Solubility | Soluble in Ethanol, Methanol, DMF, DMSO, Water |
Reference Reading
1.Meta-analysis of the effects of laidlomycin propionate, fed alone or in combination with chlortetracycline, compared with monensin sodium, fed alone or in combination with tylosin, on growth performance, health, and carcass outcomes in finishing steers in North America.
Cernicchiaro N, Corbin M, Quinn M, Prouty F, Branine M, Renter DG. J Anim Sci. 2016 Apr;94(4):1662-76. doi: 10.2527/jas.2015-0086.
The objective of this research was to use data from multiple studies to comprehensively quantify the effects of feeding 1) laidlomycin propionate (LP), alone and/or in combination with chlortetracycline, compared with 2) monensin sodium (MS), alone and/or in combination with tylosin, at commercially approved dosages, on ADG, DMI, feed efficiency (FE), mortality, and carcass characteristics (HCW and liver abscesses). A secondary objective was to explore potential sources of heterogeneity among the comparative effectiveness studies. A systematic review of peer-reviewed literature and industry reports was used to identify studies that included direct comparisons of these treatments in finishing steers in North America. Random-effects meta-analysis models of performance, carcass, and health-related outcomes were fitted with extracted data, consisting of a total of 17 data sets comprising a total of 135 pens and 13,603 steers. Results showed that pens of steers fed LP had increased ADG (live and carcass adjusted), DMI, and HCW compared with those fed monensin ( < 0.
2.Dissipation kinetics of oxytetracycline, tetracycline, and chlortetracycline residues in soil.
Li Y1, Wang H2, Liu X3, Zhao G1, Sun Y4. Environ Sci Pollut Res Int. 2016 Apr 13. [Epub ahead of print]
The dissipation of different residual states of tetracycline antibiotics (TCs) including oxytetracycline (OTC), tetracycline (TC), and chlortetracycline (CTC) laboratory microcosm systems was investigated in this study. The residues were fractionated by stepwise extractions into aqueous state (KCl solution extracts), organic state (MeOH extracts), residual state I (citric acid-sodium citrate buffer and ethyl acetate extracts) and residual state II (acetonitrile-EDTA-McIlvaine buffer extracts) for accurate evaluation of TCs pollution. The antibiotics in the aqueous state were hardly detected, whereas the antibiotics in the organic state dissipated relatively fast (not detectable within 15 days after application) and followed simple first-order kinetics (SFOK) (R 2 from 0.929 to 0.990). While first-order double-exponential decay model (FODED) (R 2 from 0.840 to 0.999) and availability-adjusted first-order model (AAFO) (R 2 from 0.939 to 0.
Recommended Products
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-03754 | CASTANOSPERMINE | Inquiry |
| BBF-03755 | Actinomycin D | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
| BBF-01825 | Loganin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
